RECEPTORS' product platform is based on our patented surface functionalization for selective binding CARATM technology. Our high-throughput methods for the development of stable, selective and scalable binding environments have broad capabilities that can be efficiently applied to product development. Proven application include bacteria and virus capture for disinfection, matrix sampling and sample preparation for infectious agent detection and diagnostics, sensing systems and sensors for clinical and industrial markets and biomarker validation for clinical diagnostics.